Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy largely ...
Stem cell and gene-based therapies hold significant promise for tissue repair and regenerative medicine, yet their clinical translation remains limited by ...
Background The role of physical activity in the risk of amyotrophic lateral sclerosis (ALS) is debated. It is also unclear whether the association differs in people at high genetic risk of ALS.
The prior three articles in this series — covering the theatrical premiere, the broadcast premiere, and Episode 1's deep physics dive — mapped The Calamity's power systems onto quantum decoherence, ...
Indian scientists at ICAR have decoded the complete, gap-free genome of arhar dal, also called tur dal or pigeonpea, for the first time. Here is what the T2T reference genome means for cheaper pulses, ...
Gene editing is like a molecular meet cute. When protein “scissors” dock onto the intended gene, even a tiny slip—no more than the width of a hydrogen atom—can ruin the connection, and the protein may ...
A couple of decades after the discovery of systems that could selectively target DNA, we’re starting to see the first therapies based on gene editing. One challenge these developments have faced is ...
Pioneering gene-editing treatments are already in clinical use, saving lives and easing the pain of devastating genetic diseases. However, the growing number of patients receiving these treatments ...
In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...
The European Union is changing its rules on gene editing. With the introduction of a two-tier system, it has freed certain types of gene-edited crops from the regulation that they would have ...
The technology, still far from clinical use, could one day prevent devastating diseases. But critics warn that even these early results may also fuel interest in commercial embryo editing, despite ...
Emerging gene-editing platforms are demonstrating that disease-causing mutations, aberrant gene expression, and even large-scale DNA insertions can be corrected without relying on error-prone DNA ...